Acquired Heart Disease and Cardiomyopathy

Ari Kannivelu
  • Duration: 1h

  • Ref. 199751

This session covers acquired heart diseases and cardiomyopathy - the causes, clinical features, investigations and management of common ones are considered.

VTE Prevention in Primary Care

Julia Czuprynska, Kim Carter and Ben Jameson
  • Duration: 1h

  • Ref. 199753

This session describes VTE prevention in the primary care setting. It aims to increase awareness of hospital-associated thrombosis and to enhance patient care before and after a hospital admission with respect to VTE prevention. It is designed for all primary healthcare workers, including GPs, nurses, health visitors, midwives a....

The Revised ISO 15189:2022 Standard Part 1 – Striving Towards Meeting User’s and Patient’s Needs

Dr Samba Diallo, Teferi Mekonen and Ms Melissa K. Meeks
  • Duration: 1h

  • Ref. 199734

This LabCoP ECHO session is the first in a four-part series dedicated to the revised ISO 15189:2022 version. In this session, we reintroduce key concepts of laboratory quality management systems (QMS) and cover some of the changes in the revised ISO 15189:2022, compared to the withdrawn ISO 15189:2012 version. In this session ho....

November Special ECHO Session Nov 2022: Local Manufacturing of Diagnostics in Africa

Prof Hassan Sefrioui and Prof Abdeladim Moumen
  • Duration: 1h 15m

  • Ref. 199738

On 17 November 2022, ASLM convened this special ECHO session on critical enablers and barriers for local manufacturing of diagnostics among African member states. The continent is heavily reliant on imported diagnostics, and in times of crisis, the continent is at greater risk, as supply chains tend to satisfy local needs first.....

Global Fund Priorities for DNO at Country Level

Patrick Royle and Nina Roguet
  • Duration: 1h

  • Ref. 199739

This LabCoP Diagnostic Network Optimisation (DNO) Sub-CoP ECHO session focuses on promoting data-driven investments for effective laboratory network optimisation. In this session, the Global Fund, provides an overview of the GF funding cycle, priorities for involvement of Lab Directorates in preparing funding request, funding fo....

6

Mr WCEA Administrator
  • Ref. 199783

Course Description here.....................

PROJECT ROZANA: Peritoneal Dialysis – Part 1

Lee Hayes & Lynn Brown
  • Duration: 30m

  • Ref. 199892

The principles of peritoneal dialysis treatment.

PROJECT ROZANA: Drug Treatment in Kidney Failure Stage 3b-5 – Part 2

Lee Hayes & Lynn Brown
  • Duration: 30m

  • Ref. 199897

Adjusting the dose of drug treatment and contraindications in renal failure.

Advanced HIV Disease (AHD)

National HIV/AIDS Control Program, Ministry of Health (NACP/MoH) in collaboration with Jhpiego
  • Duration: 1h

  • Ref. 199793

This module outlines the steps for screening for and management of Advanced HIV Disease in adults and adolescents.

Monitoring and Managing People on ARVs

National HIV/AIDS Control Program, Ministry of Health (NACP/MoH) in collaboration with Jhpiego
  • Duration: 1h

  • Ref. 199795

Welcome to this module about monitoring and managing people on ARVs.

Antiretroviral (ART) Therapy for People Living with HIV

National HIV/AIDS Control Program, Ministry of Health (NACP/MoH) in collaboration with Jhpiego
  • Duration: 1h

  • Ref. 199796

Welcome to this module about antiretroviral therapy for people living with HIV.

HIV Testing Services (HTS)

National HIV/AIDS Control Program, Ministry of Health (NACP/MoH) in collaboration with Jhpiego
  • Duration: 1h

  • Ref. 199797

Welcome to HIV Testing Services (HTS). This module focuses on the importance of HIV testing, as well as how to administer HIV tests and the different types of tests available.

Lesson 4: CAB-LA Injection Video

Jhpiego, an affiliate of Johns Hopkins University
  • Ref. 200019

This instructional video covers the preparation and administration of long-acting injectable cabotegravir (CAB-LA) used as HIV pre-exposure prophylaxis (PrEP).

Lesson 10: Method Choice: Framing Method Benefits Relative to Client Priorities

Jhpiego, an affiliate of Johns Hopkins University
  • Ref. 200025

The beauty of having multiple pre-exposure prophylaxis (PrEP) methods is that a client has the freedom to choose a method that fits with their lifestyle. To support clients to make this choice, we need to first ask what is important to them and then help them understand how available methods respond to their priorities, preferen....

Lesson 11: Cross-Cutting Counseling Techniques

Jhpiego, an affiliate of Johns Hopkins University
  • Ref. 200026

The following lessons are all about making sure that your interactions with long-acting injectable cabotegravir (CAB-LA) clients are pleasant and supportive. When clients are comfortable, it helps you as a healthcare provider get the information you need to help your clients have a good experience with pre-exposure prophylaxis (....

Introduction to Mechanisms of Specific and Non-specific Drug Action

Michael McGinlay
  • Duration: 1h

  • Ref. 200039

This session examines some of the key mechanisms by which drugs exert their physiological effect on the human body. It outlines the basic principles that govern drug-receptor interaction with relevance to drugs that are used in everyday anaesthetic practice.

Nuclear Drug Receptors

Mahry Khalili
  • Duration: 1h

  • Ref. 200045

This session describes the function and structure of intracellular nuclear receptors, including steroid and thyroid hormone receptors.

Absorption and Bioavailability

Dr Damien Wood
  • Duration: 1h

  • Ref. 200049

This session is about the pharmacokinetic principles of drug absorption and bioavailability, and factors which can influence these properties such as the process of first-pass metabolism.

Prioritisation in Intensive Care Unit

Lilian Nuwabaine
  • Duration: 2h

  • Ref. 200105

This course is aimed to equip Nurses and Midwives with knowledge and skills about Prioritization.

COVID-19 Vaccine Handling

Prof. Tumbwene Mwansisya
  • Duration: 2h

  • Ref. 200115

This course intents to provide nurses and midwives on proper COVID-19 vaccine storage and protocols for transportation. This course focuses on equipping the learner with comprehensive knowledge and skills on storage and transportation of the COVID-19 vaccine. The course will be offered through online platforms as continuing educ....

Nutrition II: Nutrition in Infants and Young Children

The Hospital for Sick Children & ADRA Canada
  • Duration: 1h

  • Ref. 200129

Good nutrition and nutrition-related behaviours are critical for a child’s healthy growth, development and survival. Globally, approximately 45 percent of deaths among children under 5 are linked to undernutrition and 22.3 percent, or more than one in five children under age 5 worldwide has stunted growth. Across Kenya, mor....

Nutrition VI: Malnutrition Management

The Hospital for Sick Children & ADRA Canada
  • Duration: 1h

  • Ref. 200133

Good nutrition and nutrition-related behaviours are critical for a child’s healthy growth, development and survival. Globally, approximately 45 percent of deaths among children under 5 are linked to undernutrition and 22.3 percent, or more than one in five children under age 5 worldwide has stunted growth. Across Kenya, mor....

Anti-Diabetic Therapy: NIDDM and Insulin Therapy in Diabetes Mellitus

Grainne Nicholson
  • Duration: 1h

  • Ref. 200072

The session covers the main classes of drugs used to treat both non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus, as well as the use of insulin and the different formulations of insulin.

Frailty, End-of-life Care and Heart Failure

Dr Sarah Zaidi
  • Duration: 1h

  • Ref. 199235

This session describes how and why we need to identify those with HF, who have coexisting frailty, and those who may be entering their last year of life. It emphasises the importance of identifying frailty, plus those with emergent EOL prognostic indicators in the most timely way and the risks of not identifying them.

Transforming Heart Failure Care Across Your Primary Care Network

Raj Thakkar
  • Duration: 30m

  • Ref. 199236

This session discusses transforming heart failure care across your Primary Care Network (PCN).